Triple Negative BC - Atezolizumab & Entinostat in Patients with Triple Negative Breast Cancer

The purpose of this study is to determine the safety and tolerability of entinostat used in combination with atezolizumab in patients with Advanced Triple Negative Breast Cancer (aTNBC). Additionally the purpose of the study is to assess how effective entinostat and atezolizumab are in combination in patients with aTNBC.

Learn More at ClinicalTrials.gov NCT 02708680
Adult Breast Cancer, Cancer